Modern Medicines and treatments can be improved with the progression of AI in medicine by discovering new drugs, personalising treatments, and speeding up chemical trials. But if the racial exclusion common in biomedical research seeps into the data behind AI there’s a risk that these medicines won’t be effective for everyone.
Artificial intelligence can help tackle the covid-19 pandemic, but bias and discrimination in its design and deployment risk exacerbating existing health inequity argue David Leslie and colleagues Among the most damaging characteristics of the covid-19 pandemic has been its disproportionate effect… A team of medical ethics researchers are arguing that bias and discrimination within AI […]
Read More
Medicine and Society from The New England Journal of Medicine — Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms Physicians still lack consensus on the meaning of race within medical science; there is an ongoing debate as to whether racial and ethnic categories can reflect underlying population genetics, and […]
Read More